{"schema":"hottub-news/story/v1","story":"st_3lxd35inolj4xkaelvea","title":"Galderma's Nemluvio shows sustained improvements in moderate-to-severe atopic dermatitis","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/galdermas-nemluvio-shows-sustained-improvements-in-moderate-to-severe-3lxd35inol","count":1,"items":[{"id":"n_3lxd35inolj4xkaelvea","seq":1357589,"kind":"article","title":"Galderma's Nemluvio shows sustained improvements in moderate-to-severe atopic dermatitis","url":"https://pmlive.com/pharma_news/galdermas-nemluvio-shows-sustained-improvements-in-moderate-to-severe-atopic-dermatitis","published":"2026-10-02T11:56:00Z","seen":"2026-10-02T13:52:51Z","lang":"en","source":{"id":"pmlive.com","name":"pmlive.com","domain":"pmlive.com"},"via":"gdelt-gkg-english","topics":["economy","education","health"],"entities":[{"id":"Q581008","name":"Galderma","type":"org"}],"story":"st_3lxd35inolj4xkaelvea","category":"health","category_p":0.4099999964237213,"sentiment":"positive","tone":0.07000000029802322,"political":0.019999999552965164}]}